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Aortic stenosis (AS) is the most common let-sided heart valve disease, and with an ageing population, the inci-
dence is set to double over the next 20 years1. Once patients with severe AS develop symptoms and reduction in 
heart function, two-year mortality can reach 50% if the valve is not replaced. Timing of intervention depends 
on an accurate assessment of not only symptoms but also of AS severity. Transthoracic echocardiography (TTE) 
is the irst-line test for the assessment of AS severity, let ventricular (LV) function and haemodynamics2,3. 
However, it is well-established that TTE has limitations – the approximation of blood low as a single stream-
line by continuous-wave Doppler TTE overestimates valvular pressure gradients compared to invasive measure-
ments4,5. his is because of the approximation of blood low as a single streamline by continuous-wave Doppler 
TTE6. In addition, the efective oriice area (EOA) is calculated using the continuity equation which includes 
many geometric and physiological assumptions, in particular, the measurement of let ventricular outlow tract 
diameter is a signiicant source of error7. If there is diagnostic uncertainty or when there is a discrepancy between 
non-invasive and the clinical assessment of AS severity, guidelines recommend invasive cardiac catheterization 
for haemodynamic assessment in symptomatic patients2.
Cardiovascular magnetic resonance (CMR) imaging already ofers a reference method for monitoring longitu-
dinal changes in LV remodelling response in patients with AS8. Four-dimensional (4D) low CMR is an emerging 
tool which allows quantifying cross-sectional x/y/z planner velocities over the complete cardiac cycle9. It has the 
advantage of identifying the true peak velocity across the three-dimensional aortic sinus and also circumvents 
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many of the issues of echocardiographic measurement such as Doppler misalignment, as well as, flow and 
geometric assumptions. Being able to identify where the maximum velocity occurs in a three-dimensional (3D) 
space is a major advantage not only over Doppler TTE but also the current standard two-dimensional (2D) 
phase-contrast CMR methods for AS assessment – which is recognised to underestimate velocities10,11.
Moreover, it allows quantiication of the EOA using the peak velocity plane, which coincides with the vena 
contracta, identiied by an evaluation of the whole three-dimensional aortic sinus low. However, there are many 
unknowns for wider adoption of these methods for AS assessment. Firstly, validation of peak velocity assessment 
by 4D low CMR for estimating peak pressure drop across the aortic valve is lacking against the reference invasive 
method. Secondly, EOA calculation using the peak velocity plane (vena contracta) on 4D low CMR has not been 
validated. hirdly, it remains unclear if 4D low CMR would ofer any incremental beneit over Doppler TTE.
hus, the main aims of this study were: (1) to validate the 4D low CMR peak velocity assessment against the 
reference invasive pressure drop assessment, (2) to validate the 4D low CMR velocity plane derived EOA against 
Doppler TTE derived EOA, (3) investigate if 4D low CMR aortic valve assessment ofers any better association to 
exercise tolerance evaluated by the six-minute walk test (6MWT) when compared to Doppler TTE, and (4) in the 
cohort with follow-up imaging studies, evaluate which measures are associated with LV remodelling.

Ǥ his was a prospective, single-centre, sub-study of the EurValve programme (http://
www.eurvalve.eu/). We recruited 18 patients with suspected severe aortic stenosis on echocardiography from the 
heart valve clinic. All patients who underwent 4D low CMR prior to any valve intervention were also invited for 
post valve intervention follow-up 4D low CMR and TTE at 3–4 months.
he inclusion criteria was clinically severe AS. he exclusion criteria were: moderate or severe aortic regur-
gitation, signiicant other valve diseases, coronary artery disease requiring coronary artery by-pass grating sur-
gery, limited pre- and post-intervention imaging data, any MRI contraindications or the inability to complete a 
six-minute walk test (6MWT).
Ethics. his study was sponsored by the Sheield Teaching Hospitals NHS Foundation Trust and approved by 
the National Research Ethics Service (17/LO/0283) in the UK. Written informed consent was obtained from all 
patients before participation. he study complied with the Declaration of Helsinki.
Ǥ All echocardiograms were performed according to the British Society of 
Echocardiography guidelines for TTE examination12. Grading of aortic stenosis was performed as per the ESC 
guidelines using mean, and peak gradients and EOA was calculated by the continuity equation2. Patients received 
TTE examination before valve intervention (3–4 months prior to the invasive study), and a follow-up TTE was 
undertaken at 3–4 months.
Invasive pressure gradient assessment. Invasive pressure gradients were obtained in all patients under-
going transcatheter aortic valve implantation (TAVI) as part of routine care prior to and post valve implantation. 
Cardiac catheterisation was performed using standard techniques via the femoral artery13. Seven-French pigtail 
catheters were placed in both the ascending aorta and the LV cavity, and simultaneous pressures were recorded14. 
he analysis was performed by the Xper CardioFlex system (Philips Healthcare, he Netherlands). Peak to peak 
pressure gradient was determined in millimetres of mercury (mmHg). his method is well established and has 
been used to deine the natural history of AS and symptomatic development.
Ǥ CMR was performed on a 3 Tesla Philips Healthcare Ingenia system equipped with a 28-channel coil 
and Philips dStream digital broadband MR architecture technology. Patients received CMR examination before 
valve intervention (3–4 months prior to the invasive study) and a follow-up CMR study was done in 3–4 months.
Ǥ he CMR protocol included a baseline survey, cines (vertical long axis, horizontal long axis, 
short‐axis contiguous let‐ventricle volume stack 3-chamber (LVOT-views) and aortic valve view cines). Cine 
images were acquired during end-expiratory breath-hold with a balanced steady-state free precession (bSSFP), 
single-slice breath-hold sequence. he number of LV short-axis slices varied according to the size of each patient’s 
heart.
Cine images had a spatial resolution of 2.5 × 2.5 mm2, interpolated to 1.56 × 1.56 mm2, and a slice thickness 
of 10 mm with contiguous slices for the short axis stack. Other imaging parameters were 30 phases, echo time 
(TE) = 1.5 ms, repetition time (TR) = 3.05 ms, lip angle = 45°, the ield of view (FOV) was 400 mm, and SENSE 
factor 2–3.
	ǦƪǤ For the 4D low CMR acquisition, the initial VENC setting was 
estimated from TTE peak velocity and tested using a through-plane two-dimensional phase contrast acquisition. 
Further increments were added until aliasing disappeared across the aortic valve. Field-of-view was planned to 
cover the whole heart, aortic valve and ascending aorta. he 4D low sequence used echo-planar imaging (EPI) 
acceleration factor of 5 with no respiratory gating. his sequence has been validated by previous studies for val-
vular low quantiication in humans at both 1.5 T and 3 T ield strengths15,16. Other standard scan parameters 
were: acquired voxel size = 3×3×3 mm, reconstructed voxel size = 1.5×1.5×1.5 mm, echo time (TE) = 3.5 ms, 
repetition time (TR) = 10 ms, lip angle 10°, the FOV 340×340 and 30 cardiac phase.
Data pre-processing was done on the scanner to correct for phase ofset errors such as eddy currents, Maxwell 
efects, and encoding errors related to gradient ield distortions to avoid impairment of the measurements and 
inaccuracies in low quantiication17,18.
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Ǥ All images were post-processed and analysed using oline research sotware called 
MASS (Version 2019 EXP, Leiden University Medical Centre, Leiden, he Netherlands). Let ventricular volumes, 
EF, and mass were calculated according to standard methods19.
	ǦƪǤ All three-phase directions were screened 
for aliasing artefact, and if present, this was manually corrected using established phase unwrapping methods20,21. 
Any spatial misalignment with cine superimposition was manually corrected throughout the cardiac cycle prior 
to any quantiication. he precise location of the maximum velocity (Vmax) in the aorta during systole was identi-
ied in the 4D low data set and the velocity recorded in a similar method to Donati et al.6 (Fig. 1).
Steps taken to identify the peak trans-valvular velocity were as follows:
1. Firstly, a valvular plane was identiied and tracked throughout the cardiac cycle (orange line in the supple-
mentary video 1).
2. Several multi-planar slices 3/4 mm apart were done above the valve to assess the quality of the low curves 
in the region of vena-contracta
3. he reformatted plane with the highest velocity and no artefact was selected. his was at the level of the vena 
contracta above the level of the valve.
Post valve intervention assessment is demonstrated in the supplementary online video. he maximum veloc-
ity determined in the 3D velocity data was used to determine the peak pressure drop by the simpliied Bernoulli 
equation = 4(Vmax)
2.
	ǦƪơƤȋȌǤ For EOA estimation, we 
applied the Bernoulli principles and the law of conservation of low at the level of vena contracta across all systolic 
phases where the valve is maximally open. Time-resolved low and velocity data were recorded, and as low = area 
* velocity, EOA was estimated using the following equation:
=EOA Flow /Vmaxt t
Acceleration of the blood through the valve in early systole and the deceleration of blood prior to valve closure 
was recorded. An estimate of EOA was acquired using a line of best it for the linear relationship of low and the 
velocity at the vena contracta and calculating the gradient of that line (Fig. 1). Velocities at diferent low rates 
throughout the systolic phases were recorded and used to reduce noise from the data, which may be higher if the 
EOA was calculated from one data point.
ǦǤ he six-minute walk test (6MWT) was carried out according to the guidelines out-
lined by the American horacic Society22. All tests were performed by the same clinician at the same location to 
avoid bias. None of the patients included had limiting arthropathy or airways disease.
Ǥ Statistical analysis was carried out with IBM SPSS Statistics version 25 software. 
Continuous measurements are presented as median with interquartile ranges (IQR). Normality of data was 
assessed by the Shapiro–Wilk test. Given the non-normal distribution of the data, a paired nonparametric 
two-tailed test (Wilcoxon signed-rank test) was used for paired analysis. Mann-Whitney test was used for all 
Figure 1. 4D low CMR for AS assessment. his igure is from a case example, which demonstrates how 4D 
low CMR was used to investigate the peak velocity across the aortic valve. Using reformatted plane through the 
peak velocity plane, systolic low and peak velocity curves were used to investigate the linear association. EOA is 
the gradient of the regression line.
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continuous variables to compare diferences between two diferent procedure options of the aortic valve; for cat-
egorical variables, P-value was calculated using Chi-squared T-Test. Correlation between variables was assessed 
by Spearman correlation coeicient (rho), Value of P < 0.05 was considered signiicant. Bland Altman plots were 
used to assess the agreement of EOA by diferent methods. Comparison of variables amongst diferent New York 
Heart Association (NYHA) functional classes was performed using the Kruskal-Wallis H test. Furthermore, a 
Jonckheere-Terpstra test was carried out to ind which speciic groups of these independent variables are signii-
cantly diferent from each other. Results with a P-value of <0.05 were considered statistically signiicant.
Results
Ǥ Eighteen patients completed the full study protocol. Of these, eight patients 
underwent TAVI and ten patients surgical aortic valve replacement (SAVR). SAVR patients were younger than 
TAVI patients (68 ± 8 vs 82 ± 11, P = 0.01), and the 6MWT was better in SAVR patients than in TAVI (409 ± 182 
meter vs 318 ± 96 meter, P = 0.02). A total of 6 post-operative patients (1 SAVR, 5 TAVI) declined to come back 
for research CMR scan. A full summary of the demographic data of the patients is shown in Table (1). Online 
Supplementary Table 1 provides detail on the type of replaced valve.
Invasive pressure gradient validation. From the whole cohort, eight pre-intervention patients and three 
post-intervention patients received invasive catheter evaluation. he peak pressure gradient by 4D low CMR was 
comparable to the invasive pressure gradient (54 ± 26 mmHG vs 50 ± 34 mmHg, P = 0.67). In contrast, Doppler 
TTE signiicantly overestimated the pressure gradient across the aortic valve when compared with invasive study 
(61 ± 32 mmHG vs 50 ± 34 mmHg, P = 0.0002) (Fig. 2). In addition, there was signiicant bias (−18.6 mmHg, 
P < 0.01) by Doppler TTE to estimate the peak pressure gradient (Fig. 3). Both Doppler TTE and 4D low CMR 
derived pressure gradients demonstrated association with the corresponding invasive assessment (r = 0.95, 
P < 0.01; r = 0.63, P = 0.04). Using a cut-of of 64 mmHg peak pressure gradient for deining severe AS, the inva-
sive assessment was more in agreement with 4D low CMR (weighted Kappa = 0.25, 95% CI −0.39 to 0.89) than 
Doppler TTE (weighted Kappa = 0.16, 95% CI −0.16 to 0.47). Online Supplementary Table 2 details per patient 
recordings.
EOA validation. Both 4Dflow and Doppler TTE derived EOAs were comparable (1.1 ± 0.5 cm2 versus 
1.2 ± 0.4 cm2, P = 0.10, bias = −0.11, P = 0.10) (Fig. 4). In addition, the 4D low derived EOA demonstrated a 
good correlation with Doppler TTE derived EOA (Fig. 5) for both pre-/post valve intervention cases.
 ?Ǥ here was a signiicant negative correlation observed between 6MWT and 4D low 
CMR derived peak pressure gradient (r = −0.45, P = 0.01), 6MWT was also signiicantly associated with 4D low 
CMR derived EOA (r = 0.54, P = 0.002) (Table 2, Fig. 5). However, the Doppler TTE derived peak pressure gradi-
ent did not demonstrate any signiicant correlation with 6MWT. Doppler-derived EOA showed good correlation 
to 6MWT (0.45, P = 0.01).
Patients chosen for 
TAVI (n = 8)
Patients chosen for 
SAVR (n = 10)
PMedian IQR Median IQR
Age (years) 82 11 68 8 0.01
Sex (Female) 8 (100%) 6 (60%) 0.05
Height (cm) 1.6 0.035 1.7 0.13 0.08
Weight (Kg) 55.8 27.25 79.9 8 0.15
BMI (kg/m²) 23.35 9.75 28.1 4.4 0.32
SysBP (mmHg) 150.5 14 156.5 25 0.63
DiaBP (mmHg) 70.5 15 76 14 0.45
HR (bpm) 63.2 11 64.85 11 0.94
IHD 1 (12.50%) 0 (0%) 0.26
DM 2 (25%) 2 (20%) 0.81
Hypertension 7 (87.50%) 5 (50%) 0.10
Creatinine 68.5 20 79.5 26 0.25
ARB blocker 0 (0%) 1 (10%) 0.37
ACEi 2 (25%) 1 (10%) 0.41
Beta blocker 2 (25%) 2 (20%) 0.81
Ca channel blocker 3 (37.50%) 3 (30%) 0.74
Loop diuretics 3 (37.50%) 1 (10%) 0.18
Peak PGTTE (mmHg) 77.6 27.5 64.6 22.3 0.12
Mean PGTTE (mmHg) 40 11 32 8 0.22
6MWT (m) 318 96.5 409 182 0.02
NYHA 2 1 2 0 0.46
Table 1. Study demographics as per the inal procedure the patient had. For all continuous variables, P-value 
was done using Mann-Whitney test. For all categorical variables, P-value was calculated using chi-squared test.
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Ǥ here was no signiicant correlation between the NYHA clas-
siication and all parameters used in this study except for pressure gradient and EOA. Doppler TTE and 4D low 
CMR pressure gradients were found to have a signiicant positive correlation with NYHA classiication (r = 0.74, 
Figure 2. Histogram chart demonstrating the mean-plots of the peak pressure gradient across the aortic 
valve in cases that had measurements for all the three modalities - invasive, Doppler TTE and 4D low CMR. 
*P < 0.05.
Figure 3. Bland-Altman plots for pressure gradients by 4D low CMR and Doppler TTE against invasive study.
Figure 4. Mean and Bland-Altman plots for EOA between TTE and 4Dlow methods.
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P < 0.001; r = 0.56, P = 0.001 respectively), Whereas, Doppler TTE and 4D low CMR EOAs were found to be 
negatively associated with NYHA classiication (r = −0.74, P < 0.001, r = −0.51, P = 0.003 respectively).
Ǥ Spearman’s correlations were computed to determine if there 
were any signiicant relationships between the relative LV mass change and the relative change in other imaging 
parameters. he correlation appears to be statistically signiicant with the relative 4D low CMR pressure gradient 
Figure 5. Correlation matrix summarises the association between the 6MWT and both TTE derived/4D 
low CMR derive PG and EOA. 6MWT correlates with 4D derived pressure gradient and efective oriice area 
in patients with severe AS and post SAVR/TAVI. Both TTE and 4D low CMR measurements demonstrate a 
correlation to each other.
NYHA 6MWT
R* P R* P
6MWT (m) −0.099 0.60
Haemodynamic parameters
BP systolic (mmgH) 0.08 0.67 0.23 0.20
BP diastolic (mmgH) 0.18 0.34 0.26 0.14
HR (bpm) −0.02 0.92 −0.27 0.22
CMR functional parameters
LVEDV (mL) 0.15 0.45 0.36 0.05
LVESV (mL) 0.13 0.52 0.24 0.19
LV mass (g) 0.33 0.08 0.13 0.49
LV SV (mL) 0.14 0.46 0.36 0.05
MR EF (%) −0.10 0.60 −0.23 0.22
Aortic valve assessment
Peak PGTTE (mmHg) 0.74 <0.01 −0.26 0.16
EOATTE (cm
2) −0.74 <0.01 0.45 0.02
Peak PG4Dlow (mmHg) 0.56 <0.01 −0.45 0.02
EOA4Dlow (cm
2) −0.51 <0.01 0.54 <0.01
Table 2. Correlation between CMR derived metrics with both qualitative symptom burden (NYHA functional 
class) and exercise tolerance measured by the 6MWT. *Spearman’s rho correlation coeicient.
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change pre/post valvular intervention (r = 0.64, P = 0.04), while TTE PG did not reach signiicance (r = 0.63, 
P = 0.06) (Table 3).

his is the irst study to validate the peak pressure gradient across the aortic valve by 4D low CMR against tran-
sthoracic echocardiography and the gold standard invasive method. In addition, we describe and validate a novel 
4D low CMR derived method for EOA measurement in pre-/post-aortic valve intervention against Doppler TTE. 
Importantly, we note that only for 4D low CMR, both pressure gradient and EOA demonstrated association to 
exercise tolerance quantiied by the 6MWT. Lastly, 4D low CMR derived peak pressure gradient demonstrated 
association to LV mass regression at three-months.
Pressure gradient assessment. Previous studies have demonstrated a discordance between the invasive 
and Doppler TTE peak pressure gradient assessment and that Doppler methods overestimate the peak pres-
sure drop7,23. Many reasons for this overestimation have been proposed. Firstly, due to the inherent diferences 
between Doppler pressure gradient method, which provides a maximum instantaneous pressure gradient at 
one-time point versus the invasive method that provides the peak-to-peak gradient which occurs at two diferent 
time points, can lead to this overestimation24. Secondly, if the gain setting on the Doppler scale is set high, it can 
lead to overestimation of peak velocity. Other reasons include human errors associated with the Doppler meth-
ods25. he 4D low CMR methods described in this study also relies on the maximum instantaneous pressure 
gradient but did not result in any overestimation. In fact, for deining severe AS, 4D low CMR derived pressure 
gradient was more consistent with the invasive method. Reduction in overestimation could be because the peak 
velocity plane was spatially identiied by velocity vector visualisation. his technique is not routinely applied in 
Doppler TTE as peak velocity assessment is made by continuous-wave Doppler, which summates all velocities in 
one direction.
Similar to our study, previous work by Allen et al. have demonstrated a systematic bias between Doppler and 
4D low CMR for the assessment of peak velocity assessment in patients with AS26. hey showed Doppler to over-
estimate peak velocities. On the contrary, Nordmeyer et al. have previously demonstrated that 4D low assessment 
results in signiicantly higher peak transvalvular low velocities (3.12 m/s versus 2.78 m/s, P < 0.05) in stenotic 
lesion when compared to Doppler27. However, the majority of patients in their study (56%) were with pulmonary 
stenosis, where Doppler alignment remains challenging. Furthermore, their patient population was diferent from 
our study. hey mainly studied younger patients (26 ± 10 years old) with bi-cuspid aortic valve disease leading 
to complex eccentric jets in the aortic root, which are diicult to align by uni-directional encoded ultrasound 
imaging methods. Hence, it is more likely that ultrasound methods will underestimate true peak velocity in their 
study cohort. Similar to Nordmeyer et al. study, Gabbour et al. demonstrated that 4D low resulted in signiicantly 
higher peak velocity than echocardiography in younger patients with various congenital heart diseases28. Both 
these studies imply that 4D low derived peak velocity assessment is possibly superior to echocardiographic meth-
ods in complex aortic valve stenotic lesions. Our study provides complementary, supportive data that 4D low 
derived peak pressure gradients across the aortic valve in mainly degenerative aortic stenosis is reliable and is in 
agreement with the invasive assessment.
ơƤǤ EOA assessment ofers complementary information when making a 
comprehensive assessment of AS. EOA is relatively pre-load independent when compared to peak velocity assess-
ment. In addition, the novel EOA derived by 4D low CMR described in this study is not subject to the geometric 
assumptions made by Doppler TTE. As this method is the gradient of the linear regression line between low and 
velocity through the aortic valve, we speculate that it is still relevant in slow low, low gradient aortic stenosis. 
Larger studies are needed to evaluate our proposed methods in these challenging cases of aortic stenosis.
Ǥ One of the most important clinical aspects to 
determine the timing of aortic valve intervention is symptom onset. his can be assessed subjectively by the 
NYHA functional class or more quantitatively by the 6MWT. More recently, studies have demonstrated that 
6MWT predicts clinical outcomes and already, in some centres, the 6MWT is now part of the routine assessment 
for patients referred for TAVI29. In this study, it was noteworthy that it was only for 4D low CMR, both pressure 
gradient and EOA were associated with both NYHA functional class and more importantly, with the 6MWT. A 
better association to the 6MWT may concur with enhanced prognostication for patients with aortic stenosis than 
Doppler TTE derived pressure gradients.
rho* P
LV EF (%) 0.27 0.40
Peak PG4Dlow (mmHg) 0.64 0.04
EOA4Dlow (cm
2) 0.25 0.45
Peak PGTTE (mmHg) 0.56 0.06
EOATTE (cm
2) −0.08 0.79
Table 3. Association of relative LV mass change to relative change in other imaging markers pre-/post aortic 
valve intervention. he relative pressure gradient change pre/post valvular intervention, determined by 4D low 
CMR correlated with the relative change of LV mass. *Spearman’s rho correlation coeicient.
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Ǥ It is well established that ater aortic valve intervention, 
the LV mass regresses with decrease in aterload. LV mass regression is independently associated with improved 
long-term survival30. It is plausible to expect a proportionate decrease in aterload, or the pressure gradient across 
the aortic valve and LV mass post aortic valve replacement. In this study, LV mass regression demonstrated a 
slightly better correlation to 4D low CMR derived pressure gradient change - again suggesting its superiority over 
the standard methods of assessment.
Ǥ his study had several limitations. One key limitation is the small number of patients recruited 
to the study. At most, this study ofers hypothesis-generating data for future larger studies, which are needed to 
further validate our indings. However, it is still plausible to conclude that 4D low CMR ofers an alternative 
non-invasive method to quantify AS and its severity. 4D low CMR is currently not widely available and requires 
a signiicant acquisition and post-processing competence, but streamlining and simpliication would facilitate 
clinical adoption. During the 4D low acquisition, respiratory navigation was omitted, which may have had an 
impact on the accuracy of derived velocity parameters. However, studies that carried out a head-to-head compari-
son of whole-heart 4D low CMR have demonstrated that for quantiication of intra-cardiac low, both respiratory 
navigated and non-respiratory navigated 4D low CMR acquisitions are comparable31. Another limitation that 
could inluence the quality of the velocity proile is a low temporal resolution (40 ms). Other confounding factors 
include variation in the heart rate and physiological conditions between the two acquisitions.
Clinical perspective. Many of the standard methods used in the assessment of AS have been shown to have 
inherent inaccuracies6,32. his includes both the non-invasive Doppler TTE and invasive assessment. Importantly, 
discordance between EOA and the pressure gradient to grade the severity of AS can further the confusion. It 
is clinically desirable to have more non-invasive tools to reduce the clinical dilemma and make an airmative 
diagnosis and grading of AS. his study demonstrates that the non-invasive, non-contrast 4D low CMR can not 
only provide a clinically relevant measurement of pressure gradient and EOA, but also that these metrics have 
enhanced association with the prognostically relevant 6MWT in patients with AS. In this study, the accuracy of 
4D low CMR pressure gradient assessment was slightly better than Doppler TTE when compared against the ref-
erence invasive methods. However, the precision was slightly lower with 4D low CMR pressure gradient. Hence, 
the results from this study suggest that in patients where Doppler TTE is inconsistent with symptoms and has 
discordant results, 4D low CMR could help in clinical decision making for deciding on aortic valve intervention.
Conclusion
4D low CMR ofers an alternative method for non-invasive assessment of aortic stenosis. In addition, 4D low 
CMR derived valve metrics have a superior association to prognostically relevant 6MWT and LV mass regression 
than TTE. Future larger studies are warranted to investigate the clinical beneit of using 4D low CMR derived AS 
severity to make clinical decisions.
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